Evaluation of Empiric Nafcillin Versus Vancomycin for Suspected Late Onset Sepsis in the Neonatal Intensive Care Unit
Use of nafcillin as the Gram-positive empiric treatment agent did not result in increased clinical worsening compared to vancomycin at our institution.
Authors
- Rupal M. Patel (ORCID: https://orcid.org/0000-0001-5966-7983)
- Jennifer Barnes (ORCID: https://orcid.org/0000-0002-9048-6694)
- Sarah Hanson (ORCID: https://orcid.org/0000-0003-4751-8248)
- Jeanne Forrester (ORCID: https://orcid.org/0000-0002-4013-0307)
- Lee Morris
- James E. Jones
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Levine Cancer Institute (US)
- Levine Children's Hospital (US)
Publication Details
- Journal
- The Journal of Pediatric Pharmacology and Therapeutics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.5863/jppt-24-00143
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00